Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06609902 · ClinicalTrials.gov registry record · NA
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
A NA study of Bipolar Disorder and Tobacco Use Disorder, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06609902 is a NA study of Bipolar Disorder and Tobacco Use Disorder that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 70 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06609902, a NA study of Bipolar Disorder and Tobacco Use Disorder, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Future Self-BD is a 6-session virtual intervention that encourages participants to vividly generate personal and positive future events that they anticipate may be benefited by smoking cessation. Each session will be conducted on HIPAA-compliant Zoom and led by the PI (Dr. Gold).
Conditions Studied
Interventions
- BEHAVIORAL Future Self-BD
- BEHAVIORAL Daily Check-Ins
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06609902
The ClinicalTrials.gov registry entry for NCT06609902 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (79% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Future Self-BD is the first listed.
NCT06609902 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06609902 about?
NCT06609902 is a clinical study titled "A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder". Future Self-BD is a 6-session virtual intervention that encourages participants to vividly generate personal and positive future events that they anticipate may be benefited by smoking cessation. Each session will be conducted on HIPAA-compliant Zoom and led by the PI (Dr. Gold).
What is the current status of trial NCT06609902?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-12-06. Estimated completion is 2028-04-30.
What conditions does trial NCT06609902 study?
This clinical trial studies the following conditions: Bipolar Disorder, Tobacco Use Disorder.
What interventions are being tested in trial NCT06609902?
The interventions under investigation include: Future Self-BD (BEHAVIORAL), Daily Check-Ins (BEHAVIORAL).
Who is sponsoring clinical trial NCT06609902?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06609902 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.